1,365
Views
4
CrossRef citations to date
0
Altmetric
Case Report

An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report

, &
Pages 4102-4104 | Received 25 Jun 2021, Accepted 29 Aug 2021, Published online: 07 Oct 2021

References

  • Palacios R, Patiño EG, de Oliveira Piorelli R, Conde M, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF, et al. Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by sinovac - PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:853.
  • Zhang MX, Zhang TT, Shi GF, Cheng FM, Zheng YM, Tung TH, Chen HX. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China. Expert Rev Vaccines. 2021;20:891–98.
  • Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100:135–41. doi:10.1136/bjophthalmol-2015-306629.
  • Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rhumatol. 2002;29:288–91.
  • Bonilla FA. Update: vaccines in primary immunodeficiency. J Allergy Clin Immunol. 2018;141:474–81. doi:10.1016/j.jaci.2017.12.980.
  • Liu H, Zhang J, Zhou P, Sun H, Katsarou M, Drakoulis N. Exploration of vascular adhesion protein-1 expression in patients with conjunctivitis associated systemic lupus erythematosus using 2D-DIGE. Exp Ther Med. 2019;18:5072–77.
  • Kuniyoshi K, Hatsukawa Y, Kimura S, Fujino T, Ohguro H, Nakai R, Sunami K, Mishima SI, Sato T, Kusaka S, et al. Acute bilateral photoreceptor degeneration in an infant after vaccination against measles and rubella. JAMA Ophthalmol. 2017;135:478–82.
  • Cheng JY, Margo CE. Ocular adverse events following vaccination: overview and update. Surv Ophthalmol. 2021. doi:10.1016/j.survophthal.2021.04.001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.